These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 37071501
1. Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors. Ou JY, Bennion N, Parker K, Fair D, Hanson HA, Kepka D, Warner EL, Ramsay JM, Kaddas HK, Kirchhoff AC. Cancer Epidemiol Biomarkers Prev; 2023 May 01; 32(5):625-633. PubMed ID: 37071501 [Abstract] [Full Text] [Related]
4. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study. Bright CJ, Reulen RC, Winter DL, Stark DP, McCabe MG, Edgar AB, Frobisher C, Hawkins MM. Lancet Oncol; 2019 Apr 01; 20(4):531-545. PubMed ID: 30797674 [Abstract] [Full Text] [Related]
6. Human papillomavirus-associated subsequent malignant neoplasms among childhood cancer survivors. Jia Y, Liu X, Li X, Wu K. Cancer Epidemiol; 2024 Oct 01; 92():102646. PubMed ID: 39137588 [Abstract] [Full Text] [Related]
7. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort. Turcotte LM, Liu Q, Yasui Y, Henderson TO, Gibson TM, Leisenring W, Arnold MA, Howell RM, Green DM, Armstrong GT, Robison LL, Neglia JP. J Clin Oncol; 2019 Dec 01; 37(34):3310-3319. PubMed ID: 31622130 [Abstract] [Full Text] [Related]
8. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor. Henderson TO, Fowler BW, Hamann HA, Nathan PC, Whitton J, Leisenring WM, Oeffinger KC, Neglia JP, Turcotte LM, Arnold MA, Conces MR, Howell RM, Robison LL, Armstrong GT, Alexander KA. Cancer; 2022 Jan 15; 128(2):373-382. PubMed ID: 34606625 [Abstract] [Full Text] [Related]
9. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. Suk R, Mahale P, Sonawane K, Sikora AG, Chhatwal J, Schmeler KM, Sigel K, Cantor SB, Chiao EY, Deshmukh AA. JAMA Netw Open; 2018 Sep 07; 1(5):e181999. PubMed ID: 30646145 [Abstract] [Full Text] [Related]
11. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort. Turcotte LM, Whitton JA, Friedman DL, Hammond S, Armstrong GT, Leisenring W, Robison LL, Neglia JP. J Clin Oncol; 2015 Nov 01; 33(31):3568-75. PubMed ID: 26261260 [Abstract] [Full Text] [Related]
12. Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers. Trama A, Vener C, Lasalvia P, Bernasconi A, Ada Working Group. Front Oncol; 2022 Nov 01; 12():823115. PubMed ID: 35280767 [Abstract] [Full Text] [Related]
14. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM. Blood Adv; 2019 Jul 09; 3(13):1961-1969. PubMed ID: 31262739 [Abstract] [Full Text] [Related]
15. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor. Lee JS, Padilla B, DuBois SG, Oates A, Boscardin J, Goldsby RE. Pediatr Blood Cancer; 2015 Jul 09; 62(7):1259-64. PubMed ID: 25809878 [Abstract] [Full Text] [Related]
16. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea. Ju HY, Moon EK, Lim J, Park BK, Shin HY, Won YJ, Park HJ. PLoS One; 2018 Jul 09; 13(11):e0207243. PubMed ID: 30440007 [Abstract] [Full Text] [Related]
17. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM, DCOG LATER Study Group. J Clin Oncol; 2017 Jul 10; 35(20):2288-2298. PubMed ID: 28530852 [Abstract] [Full Text] [Related]
18. Age at Primary Malignancy Determines Survival in Adolescent and Young Adults That Develop a Secondary Thyroid Cancer. Lau BJ, Goldfarb M. J Adolesc Young Adult Oncol; 2016 Jun 10; 5(2):201-8. PubMed ID: 27042962 [Abstract] [Full Text] [Related]
19. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB. J Natl Cancer Inst; 2007 Nov 07; 99(21):1634-43. PubMed ID: 17971527 [Abstract] [Full Text] [Related]
20. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Nelson RA, Lai LL. Cancer; 2017 Oct 15; 123(20):4013-4021. PubMed ID: 28608917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]